Close Menu

NEW YORK (360Dx) – OraSure Technologies reported after the close of the market on Wednesday that its fourth quarter revenues fell 3 percent year over year, largely due to an 11 percent dip in net product revenues during that period.

For the three months ended Dec. 31, 2018, the point-of-care diagnostic testing and specimen collection device manufacturer reported revenues of $50.2 million, down from $52.0 million a year earlier but beating the average Wall Street estimate of $47.8 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.